Cargando…
The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer
INTRODUCTION: Nanobubble is an innovative ultrasound contrast agent that triggers the development of targeted imaging of HER2-positive breast cancer by combining with HER2 affibody and IR783. HPPH is a second-generation photosensitiser that is effective in treating tumours. Hence, the nanobubble-IR7...
Autores principales: | Cai, Wenbin, Lv, Wei, Meng, Li, Duan, Yunyou, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871049/ https://www.ncbi.nlm.nih.gov/pubmed/36703724 http://dx.doi.org/10.2147/IJN.S387409 |
Ejemplares similares
-
Immunomodulatory activity of IR700-labelled affibody targeting HER2
por: Mączyńska, Justyna, et al.
Publicado: (2020) -
The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai, Wenbin, et al.
Publicado: (2018) -
Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
por: Yang, Hengli, et al.
Publicado: (2021) -
IR-783 inhibits breast cancer cell proliferation and migration by inducing mitochondrial fission
por: Li, Pantong, et al.
Publicado: (2019) -
Thermotropic effects of PEGylated lipids on the stability of HPPH-encapsulated lipid nanoparticles (LNP)
por: Kalyanram, Poornima, et al.
Publicado: (2021)